Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Health Technology Assessment (Winchester, England)|August 8, 2020
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility studyAshley P Jones, Dannii Clayton, Gloria Nkhoma, et al.
Rheumatology (Oxford, England)|September 11, 2024
Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric studySathish Kumar, Akagri Chugh, Samantha Cheryl Kumar, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Clinical Immunology (Orlando, Fla.)|April 25, 2023
Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO)C M Hedrich, M W Beresford, F Dedeoglu, et al.
The Lancet. Respiratory Medicine|March 7, 2021
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trialArvinder S Soin, Kuldeep Kumar, Narendra S Choudhary, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Health Technology Assessment (Winchester, England)|April 30, 2019
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCTAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
AMRC Open Research|May 6, 2024
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised SclerodermaYasin Desai, Thomas Jaki, Michael W Beresford, et al.
Pageof 25